Fundacion Para La Investigacion Biomedica De Cordoba
Fundacion Para La Investigacion Biomedica De Cordoba is recorded as a service provider in 4 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 4 of 4 trials · Latest update first
A Prospective, randomized, single blind, multicenter Phase III study on organ preservation with Custodiol-N solution compared with Custodiol solution in liver transplantation
Sponsor Dr. Franz Koehler Chemie GmbH
- Start (EU)
- Latest update
- Estimated end
- Not reported
Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia
Sponsor Universitair Medisch Centrum Utrecht
- Start (EU)
- Latest update
- Estimated end
- Not reported
Effect of Vitamin D supplementation on MyocardIal Fibrosis in PaTients with Acute Myocarditis (EDIT-AM): a multicenter, open-label, randomized controlled trial
Sponsor Spanish Society Of Cardiology
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
A Phase IIa Open Label, Dose-Finding, Clinical Trial to Evaluate Safety, Tolerability and Preliminary Efficacy of Etrinabdione in Patients with Peripheral Arterial Disease (PAD). CLAUDIA Trial
Sponsor Vivacell Biotechnology Espana S.L.
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Fundacion Para La Investigacion Biomedica De Cordoba?
The 2026-10-09 snapshot links Fundacion Para La Investigacion Biomedica De Cordoba to 4 distinct CTIS trials. Recorded services include Regulatory services, Clinical monitoring, Electronic data capture, Project management, among 5 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Fundacion Para La Investigacion Biomedica De Cordoba?
The most frequently recorded therapeutic areas are Hepatology, Surgery and Perioperative Care, Transplantation. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Fundacion Para La Investigacion Biomedica De Cordoba conducted?
The linked trials record locations in 13 countries, including Spain, Belgium, Czechia, Germany, Estonia. These are trial locations, not confirmed office locations or countries where Fundacion Para La Investigacion Biomedica De Cordoba delivered services.
What can this page tell me about Fundacion Para La Investigacion Biomedica De Cordoba's trial experience?
Browse 4 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Fundacion Para La Investigacion Biomedica De Cordoba. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Fundacion Para La Investigacion Biomedica De Cordoba